+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effects of Sera from Uninephrectomized Rats on Renal Slices: PAH and TEA Uptake and QO 2

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          We followed the effects of sera from unilaterally nephrectomized (uninephectomized) rats compared to sham-operated rats on <sup>3</sup>Η- p-aminohippurate (<sup>3</sup>H-PAH) and <sup>14</sup>C-tetraethylammonium (<sup>14</sup>C-TEA) uptake and oxygen comsumption (QO<sub>2</sub>) in incubating rat kidney slices. These studies were based on the assumption that a circulating renotropic substance might also influence various transport mechanisms. Sera were obtained at various times postoperation; the height of renotropic activity occurs 17–24 h after kidney extirpation. Sera removed 17–24 h postuninephrectomy significantly decreased both <sup>3</sup>H-PAH and <sup>14</sup>C-TEA uptake in incubating kidney slices. Similar to the inability to show significant renotropic activity after 36 h, sera obtained 48,96, and 168 h postuninephrectomy had no significant influence on <sup>3</sup>H-PAH and <sup>14</sup>C-TEA uptake. Addition of sera (10% v/v) generally depressed QO<sub>2</sub>. However, sera obtained from uninephrectomized rats compared to sera from sham-operated rats had relatively more depressive effects on QO<sub>2</sub> in renal tissue after 30 min of incubation (p < 0.01). No significant differences in QO<sub>2</sub> were seen when the uninephrectomized and sham-operated sera were added to the tissue immediately or after 60 min of incubation in the sera. These serum studies on <sup>3</sup>H-PAH and <sup>14</sup>C-TEA uptake simulate in many respects ones performed previously with serum from spontaneously hypertensive and salt-loaded rats and suggest the presence of a common circulating factor.

          Related collections

          Author and article information

          S. Karger AG
          05 December 2008
          : 45
          : 1
          : 59-64
          Departments of Medicine (Nephrology) and Pathology, Georgetown University Medical Center, Washington, D.C., USA
          184073 Nephron 1987;45:59–64
          © 1987 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Original Paper


          Comment on this article